Search

everythinglearnresearchcommunity

for

Search:↓

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Most women with PCOS have insulin resistance, especially those with phenotype B.

PCOS often causes skin issues like excess hair, acne, and hair loss, needing early treatment.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Being overweight or obese before pregnancy increases the risk of having a C-section and a larger-than-normal baby in Chile's public health system.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Adiponectin may stimulate hair growth and could be a potential treatment for promoting hair growth.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Low selenium levels can extend lifespan but worsen health issues.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

The free androgen index varies among women with different types of PCOS.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.